Sequus Pharmaceuticals, Inc.
🏢 View company profile →16Patents
0Active
16Granted
35Portfolio score
Filing activity: Mar 27, 1992 → Mar 2, 2000
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5631018A | Lipid-polymer conjugates and liposomes | Emerging Cross-Sectional Technologies | 214 | Expired |
| US6056973A | Therapeutic liposome composition and method of preparation | Emerging Cross-Sectional Technologies | 187 | Expired |
| US5891468A | Fusogenic liposome compositions and method | Emerging Cross-Sectional Technologies | 131 | Expired |
| US6316024A | Therapeutic liposome composition and method of preparation | Emerging Cross-Sectional Technologies | 126 | Expired |
| US5527528A | Solid-tumor treatment method | Emerging Cross-Sectional Technologies | 125 | Expired |
| US5620689A | Liposomes for treatment of B-cell and T-cell disorders | Emerging Cross-Sectional Technologies | 100 | Expired |
| US5945122A | Liposomes containing a cisplatin compound | Human Necessities | 96 | Expired |
| US6180134A | Enhanced ciruclation effector composition and method | Emerging Cross-Sectional Technologies | 69 | Expired |
| US5843473A | Method of treatment of infected tissues | Chemistry; Metallurgy | 67 | Expired |
| US6043094A | Therapeutic liposome composition and method | Human Necessities | 48 | Expired |
| US6126966A | Liposomes containing a cisplatin compound | Human Necessities | 41 | Expired |
| US5972379A | Liposome composition and method for administering a quinolone | Human Necessities | 37 | Expired |
| US6224903A | Polymer-lipid conjugate for fusion of target membranes | Human Necessities | 31 | Expired |
| US6133026A | Condensed plasmid-liposome complex for transfection | Human Necessities | 17 | Expired |
| US5851818A | Condensed plasmid-liposome complex for transfection | Chemistry; Metallurgy | 14 | Expired |
| US6326353A | Enhanced circulation effector composition and method | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.